Stem-like signatures in human meningioma cells are under the control of CXCL11/CXCL12 chemokine activity
Federica Barbieri(University of Genoa), Tullio Florio(University of Genoa), Davide De Pietri Tonelli(Italian Institute of Technology), Stefano Thellung, Piero Schiapparelli(Ente Ospedaliero Ospedali Galliera), Silvia Rancati(Italian Institute of Technology), Aldo Pagano(Ospedale Policlinico San Martino), Gabriele Gaggero(Ospedale Policlinico San Martino), Pietro Fiaschi(Ospedale Policlinico San Martino), Giuseppa De Luca(Ospedale Policlinico San Martino), Irene Dellacasagrande(University of Genoa), Gianluigi Zona(Ospedale Policlinico San Martino), Irene Appolloni(University of Genoa), Mariella Dono(Ospedale Policlinico San Martino), Davide Ceresa(University of Genoa), Paolo Nozza, Monica Gambaro(Ente Ospedaliero Ospedali Galliera), Roberto Würth, Nicolò Costanzo(University of Genoa), Adriana Bajetto(University of Genoa), Paolo Malatesta(Ospedale Policlinico San Martino), Agnese Solari(University of Genoa), Virginia Fernández(University of Chile)
Cited by 24
Related Papers
Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas
|Journal of Clinical Oncology|2017|345
MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis
|Nature Cancer|2022|224
Eradication of glioblastoma by immuno-virotherapy with a retargeted oncolytic HSV in a preclinical model
|Oncogene|2019|78
New Molecules and Old Drugs as Emerging Approaches to Selectively Target Human Glioblastoma Cancer Stem Cells
|BioMed Research International|2014|64